(NASDAQ: THMO) Thermogenesis Holdings's forecast annual revenue growth rate of 40.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.94%.
Thermogenesis Holdings's revenue in 2024 is $9,445,000.On average, 1 Wall Street analysts forecast THMO's revenue for 2024 to be $134,060,012, with the lowest THMO revenue forecast at $134,060,012, and the highest THMO revenue forecast at $134,060,012. On average, 1 Wall Street analysts forecast THMO's revenue for 2025 to be $187,049,386, with the lowest THMO revenue forecast at $187,049,386, and the highest THMO revenue forecast at $187,049,386.
In 2026, THMO is forecast to generate $203,193,529 in revenue, with the lowest revenue forecast at $203,193,529 and the highest revenue forecast at $203,193,529.